FDA Nails Tennessee Compounder for Lack of Endotoxin Testing

Drug Industry Daily
A A
The FDA knocked compounding pharmacy People’s Custom Rx and Clinical Care with a Form 483, taking the firm to task over unsanitary practices and a failure to conduct endotoxin testing on finished products.

To View This Article:

Login

Subscribe To Drug Industry Daily